Sensitivity of the activated partial thromboplastin time, the dilute Russell's viper venom time, and the kaolin clotting time for the detection of the lupus anticoagulant: A direct comparison using plasma dilutions

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 1, 1996, Pages 31-38

  Martin, B A ^a   Branch, D W ^a   Rodgers, G M ^b,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c ARUP LABORATORIES   (United States)

Author keywords

Activated partial thromboplastin time; Antiphospholipid antibodies; Dilute Russell's viper venom time; Kaolin clotting time; Lupus anticoagulant

Indexed keywords

KAOLIN; LUPUS ANTICOAGULANT; VIPER VENOM;

ADULT; ARTICLE; ASSAY; BLOOD CLOTTING; CLINICAL ARTICLE; FEMALE; HUMAN; PLASMA; PRIORITY JOURNAL; THROMBOPLASTIN TIME;

HUMANS; INDICATOR DILUTION TECHNIQUES; LUPUS COAGULATION INHIBITOR; PARTIAL THROMBOPLASTIN TIME; PHOSPHOLIPIDS; PROTHROMBIN TIME; SENSITIVITY AND SPECIFICITY;

EID: 0029928074     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199601000-00004     Document Type: Article

References (37)

1. Pengo V, Thiagarajan P, Shapiro SS, Heine MJ. Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood 1987; 70: 69-76.
2. Kelsey PR, Stevenson KJ, Poller L The diagnosis of lupus anticoagulants by the activated partial thromboplastin time - the central role of phosphatidylserine. Thromb Haemost 1984; 52: 172-175.
3. Rauch J, Tannenbaum M, Tannenbaum H, et al. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J Biol Chem 1986; 261: 9672-9677.
4. Martin BA, Branch DW, Rodgers GM. The preparation of a sensitive partial thromboplastin reagent from bovine brain. Blood Coag Fibrinol 1992; 3: 287-294.
5. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68: 869-874.
6. Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40: 143-151.
7. Lupus Anticoagulant Working Party. Guidelines on testing for the lupus anticoagulant. J Clin Path 1991; 44: 885-889.
8. Triplett DA, Brandt JT, Kaczor D, Schaeffer J. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983; 79: 678-682.
9. Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. Thromb Haemost 1991; 65: 320-322.
10. Exner T. Comparison of two simple tests for the lupus anticoagulant. Am J Clin Pathol 1985; 83: 215-218.
11. Sletnes KE, Graven K, Wisloff F. Preparation of plasma for the detection of lupus anticoagulants and antiphospholipid antibodies. Thromb Res 1992; 66: 43-53.
12. Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin: a simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol 1961; 36: 212-219.
13. Stevenson KJ, Easton AC, Curry A, Thomson JM, Poller L The reliability of activated partial thromboplastin time methods and the relationship to lipid composition and ultrastructure. Thromb Haemost 1986; 55: 250-258.
14. Reed AH, Henry RJ, Mason WB. Influence of statistical methods used on the resulting estimate of normal range. Clin Chem 1971; 17: 275-284.
15. Triplett DA, Brandt JT. Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon. Hematol Pathol 1988; 2: 125-143.
16. Alving BM, Baldwin PE, Richards RL, Jackson, BJ. The dilute phospholipid APTT: a senstive assay for verification of lupus anticoagulants. Thromb Haemost 1985; 54: 709-712.
17. Triplett DA, Brandt JT, Maas RL. The laboratory heterogeneity of lupus anticoagulants. Arch Pathol Lab Med 1985; 109: 946-951.
18. Mannucci PM, Canciani MT, Mari D, Meucci P. The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupuslike anticoagulant. Scand J Haematol 1979; 22: 423-432.
19. Triplett DA. Screening for the lupus anticoagulant. Res Clin Lab 1989; 19: 379-389.
20. Howarth S. Activated partial thromboplastin time reagents: an evaluation. Br J Biomed Sci 1993; 50: 109-113.
21. Brandt JT, Triplett DA, Rock WA, Bovill EG, Arkin CF. Effect of lupus anticoagulant on the activated partial thromboplastin time. Arch Pathol Lab Med 1991; 115: 109-114.
22. Ko J, Guaglianone P, Wolin M, Murillo P, Runge A, Baum LG. Variation in sensitivity of an activated partial thromboplastin time reagent to the lupus anticoagulant. Am J Clin Pathol 1993; 99: 333 (abstract).
23. Green D, Hougie C, Kazmier FJ, et al. Report of the working party on acquired inhibitors of coagulation: studies of the 'lupus' anticoagulant. Thromb Haemost 1983; 49: 144-146.
24. Gibson J, Starling E, Date L, Rickard KA, Kronenberg H. Simplified screening procedure for detecting lupus inhibitor. J Clin Pathol 1988; 41: 226-231.
25. Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust NZ J Med 1990; 20: 231-236.
26. The Lupus Anticoagulant Working Party. Detection of lupus like anticoagulant: current laboratory practice in the United Kingdom. J Clin Pathol 1990; 43: 73-75.
27. Legnani C, Palareti G, Boggian O, et al. An evaluation of several laboratory tests and test combinations in the detection of lupus anticoagulant. Int J Clin Lab Res 1992; 22: 106-110.
28. Exner T, Triplett DA, Taberner DA, Howard MA, Harris EN. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1). Tbromb Haemost 1990; 64: 478-484.
29. Lo SCL, Oldmeadow MJ, Howard MA, Firkin BG. Comparison of laboratory tests used for identification of the lupus anticoagulant. Am J Hematol 1989; 30: 213-220.
30. Exner T, Rickard KA, Kronenberg H. Studies on phospholipids in the action of a lupus coagulation inhibitor. Pathology 1975; 7: 319-328.
31. II phases necessary? Br J Haematol 1994; 86: 583-589.
32. Exner T, Papadopoulos G, Koutts J. Use of a simplified dilute Russell's viper venom time (DRVVT) confirms heterogeneity among 'lupus anticoagulants'. Blood Coagul Fibrinolysis 1990; 1: 259-266.
33. Lesperance B, David M, Rauch J, Infante-Rivard C, Rivard GE. Relative sensitivity of different tests in the detection of low titer lupus anticoagulants. Thromb Haemost 1988; 60: 217-219.
34. O'Neill AI, Ibrahim KMA, Des Parkin J. Automation of the kaolin clotting time. Pathology 1992; 24: 12-14.
35. Exner T. Similar mechanism of various lupus anticoagulants. Thromb Haemost 1985; 53: 15-18.
36. Working Group on Hemostasis of the Société Francaise de Biologie Clinique. Comparison of a standardized procedure with current laboratory practices for the detection of lupus anticoagulant in France. Thromb Haemost 1993; 70: 781-786.
37. Stark RA, Gordon S. Comparison of four laboratory tests for lupus anticoagulant. Pathology 1990; 22: 122-123.